Company Search:
Advanced Search
Sponsored Links
Vericel Corp Company Snapshot
Vericel Corp operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vericel Corp with three other companies in this sector in the United States: Acceleron Pharma Inc (2016 sales of $27.77 million ), Apollo Endosurgery Inc ($64.87 million of which 50% was Surgical), and Teligent Inc ($66.88 million of which 100% was Cosmetic Products).

Sales Analysis. Vericel Corp reported sales of $54.38 million for the year ending December of 2016. This represents an increase of 6.3% versus 2015, when the company's sales were $51.17 million. This was the third consecutive year of growth at Vericel Corp.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vericel Corp
  Stock Performance Chart for Vericel Corp
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 6.63
(Figures in U.S. Dollars)
1 Week 13.2%   13 Weeks 41.0%  
4 Weeks 36.6%   52 Weeks 124.6%  
Vericel Corp Key Data:
  Ticker: VCEL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 54,383,000
(Year Ending Jan 2017).
Employees: 202
  Currency: U.S. Dollars Market Cap: 230,894,500
  Fiscal Yr Ends: December Shares Outstanding: 34,852,000
  Share Type: Common Closely Held Shares: 3,054,209
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.